Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

UK In Silico Regulatory Innovation Task Force

UK In Silico Regulatory Innovation Task Force

BACK

UK In Silico Regulatory Innovation Task Force

Mission: Nurture a cross-sector UK in silico trials community for regulatory science & innovation to produce evidence and harmonize standards in the UK accelerating in silico adoption in regulations

The UK In Silico Regulatory Innovation Task Force is making waves in the field of medical research. Led by Alejandro Frangi (University of Manchester) and David Flynn (Boston Scientific), this group is dedicated to nurturing a collaborative environment that advances in silico clinical trials and paves the way for their wider adoption.

Their efforts hold the potential to revolutionise medical research, leading to faster development of life-saving treatments for patients worldwide.

The Task Force champions UK standardisation efforts through organisations like BSI (British Standards Institution) and fosters collaboration with international counterparts like the FDA (US Food and Drug Administration) and EMA (European Medicines Agency). This collaborative effort will ensure consistency and facilitate the global acceptance of in silico trials.

Goals

  • Facilitating intra-UK and UK-international dialogue promoting adoption of in silico regulatory science and innovation.
  • Develop the evidence for in silico trials and predictive medicine as a response to the TIGR Report.
  • Actively engage with UK Government, Trade Associations, Standardisation Bodies, Regulators & Policy makers.
  • Map out the economic impact and supply chain for the UK economy of in silico regulatory science and innovation.
  • Promote UK standardisation efforts (e.g., via BSI etc.) with international standardisation initiatives.
  • Promote collaboration between MHRA, FDA and EMA around medical products regulatory science and innovation

Alejandro Frangi

Alejandro Frangi

Co-chair of the UK In Silico Regulatory Innovation Task Force

University of Manchester

READ BIO
David Flynn

David Flynn

Co-chair of the UK In Silico Regulatory Innovation Task Force

Fellow CM&S, Boston Scientific

READ BIO

NEWS

News ADVANCING THE VIRTUAL HUMAN TWIN ECOSYSTEM - Avicenna Alliance at VHT Net Initiative Meeting

ADVANCING THE VIRTUAL HUMAN TWIN ECOSYSTEM - Avicenna Alliance at VHT Net Initiative Meeting

On 20 October, Avicenna Alliance was represented by many members and partners, including our President and Secretary General, Thierry Marchal, at the annual VHT Net initiative meeting, organised by the VPH - The Society for In Silico Medicine at the European Commission.

News SILICA General Assembly - Strengthening collaboration on AI, synthetic data and in silico methods in healthcare

SILICA General Assembly - Strengthening collaboration on AI, synthetic data and in silico methods in healthcare

The Avicenna Alliance is pleased to support initiatives that bring stakeholders together to advance the use of artificial intelligence, synthetic data, and computational modelling and simulation in healthcare.

News Avicenna Days (AAD) 2027

Avicenna Days (AAD) 2027

Three days. One journey. From research to real-world impact.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2026 Avicenna Alliance | powered by We Berry